This company provides on-demand strategic biopharma intelligence by leveraging a vast, proprietary database of structured data, filings, and research documents. They offer competitive landscape analysis, custom briefings, and integration of internal data to support decision-making regarding indication prioritization and market positioning. The platform ensures data security and provides auditable citations for all generated insights.
Funding
$7.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Biopharmaceutical analysts face challenges in efficiently interrogating vast amounts of clinical trial data from disparate sources. Traditional methods often involve manual data collection and analysis, leading to delays in identifying key insights and testing hypotheses. This can hinder timely decision-making in investment and research strategies.
Solution
Sleuth provides a machine learning-powered platform designed to streamline data analysis workflows for biopharma analysts. The platform aggregates and structures over 100 million data points from diverse sources, including clinical trials, regulatory filings, patents, and conference transcripts, with a focus on global data, including data from China. Sleuth enables users to test hypotheses in real-time and identify related trials, facilitating faster, data-driven decision-making. Users can either leverage the AI software platform directly or partner with Sleuth analysts to receive tailored, presentation-ready reports and actionable insights. The platform's AI agents monitor data sources 24/7, ensuring users never miss critical market movements.
Target Audience
The primary target audience includes biopharmaceutical analysts, investment firms, and research teams who require efficient access to and analysis of comprehensive clinical trial data for competitive intelligence, investment decisions, and research strategies.
Features
- AI-powered analysis of 100M+ biopharma data points, including hard-to-find data such as China pipeline activity, event transcripts, and analyst research
- Proprietary structured database with drugs, clinical trials, deals, targets, and indications
- AI software platform to build outputs and analyses, using the same tools as Sleuth analysts
- Option to submit requests and receive back finished deliverables, such as polished reports and presentation-ready slides
- Auditable citations for easy verification of responses and source data
- Secure data handling, with options to upload internal data without training models or sharing data externally
- API access available on a case-by-case basis